abstract |
The present invention provides a new class of 4,5-diaryl-3 (2H) -furanone derivatives, which strongly and selectively inhibit COX-2 over COX-1. They are useful for treating inflammation, disorders associated with inflammation and diseases mediated by COX-2. |